Médecins pour Typage HLA à l'étranger — Page 2

Dr. Umit Ozcelik is a transplant surgeon at Valued Med Hub Hospitals in Istanbul. He performs liver and kidney transplants for both adults and children. Dr. Ozcelik trained at Ankara University and specializing in general surgery at Baskent University. He treats complex conditions requiring hepatobiliary surgery and HLA-typing.

• Performs pediatric and adult organ transplants.
• Expertise in hepatobiliary surgery and breast cancer treatment.
• Completed specialized training in anorectal diseases and burn care.
• Works at a center with an International Health Tourism Authorization Certificate.

Le médecin se spécialise en oncologie, se concentrant sur les évaluations préchirurgicales, la détection du cancer et la fourniture de seconds avis sur la nutrition et le mode de vie dans les soins du cancer. Avec une formation en médecine interne, le médecin a effectué un stage de recherche au M. D. Anderson Cancer Center et détient une thèse de doctorat de l'Université médicale de Vienne. Le médecin a été chef de service à l'Hôpital universitaire de médecine interne I à Vienne et dirige actuellement la Clinique privée Josefstadt. Le médecin a publié plus de 120 articles scientifiques et est membre du conseil d'administration de la Société autrichienne d'hématologie et d'oncologie.<\/p>

Dr. Hasan Atilla Ozkan is a hematologist at VM Medical Park Pendik Hospital in Istanbul. He is the President of the Turkish Therapeutic Apheresis Association. Dr. Ozkan specializes in stem cell transplantation and hematological oncology. He received the Young Researcher Award at the 6th Turkish Therapeutic Apheresis Congress.

• Expert in autologous and allogeneic bone marrow transplantation.
• Treats complex blood disorders including leukemia, lymphoma, and myeloma.
• Certified in clinical phytotherapy and flow cytometry application.
• Full member of the European Bone Marrow Transplantation (EBMT) group.

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Professor Fan Yu is Chief Physician and Director of Kidney Transplantation. His center ranked first in Fujian for three straight years in liver and kidney transplants. His team performed 112 kidney transplants and one combined liver-kidney transplant over two years.

He specializes in kidney transplantation, post-transplant complications, and immunosuppressive management. He developed a system to improve long-term graft and patient survival.

He pioneered the diagnosis and treatment of chronic and subclinical rejection. He has led more than 10 grants as principal investigator and published over 30 SCI-indexed papers. He is Vice Chairman of the Transplant Surgeon Branch of the Chinese Medical Doctor Association and the Organ Transplant Branch of the Shanghai Medical Association. He is Editor-in-Chief of Chinese Kidney Friends and serves on the editorial boards of over 20 journals, including the Chinese edition of Transplantation.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Avec 20 ans de pratique, la docteure se spécialise en hématologie et oncologie pédiatriques, en se concentrant sur les maladies rares du cancer du sang. Elle a réalisé plus de 3 500 greffes de moelle osseuse, gagnant une réputation parmi les patients comme celle qui "transplante la vie."

Son expertise et son dévouement ont été reconnus par Forbes, qui l'a nommée l'une des meilleures médecins en 2018.

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Le médecin a obtenu son diplôme de la faculté de médecine de Hacettepe en 1985 et est devenu spécialiste en médecine interne à l'Université d'Ege en 1990. Pour approfondir son expertise, le médecin s'est spécialisé en hématologie et a obtenu un doctorat à l'École de médecine de Mie au Japon en 1995. En 1997, le médecin a été promu professeur assistant, puis professeur d'hématologie à l'Université d'Ege. En 2003, le médecin a continué en tant que professeur d'hématologie à l'Université technique de Karadeniz. Avec plus de 65 articles scientifiques, 112 communications lors de réunions et 34 présentations lors de conférences, le médecin est reconnu pour ses contributions à l'hématologie et à la transplantation de moelle osseuse.<\/p>

Dr. Rafet Eren is a hematologist at Biruni University Hospital in Istanbul. He specializes in treating leukemia, lymphoma, and myeloma. Dr. Eren is an Associate Professor with around 50 scientific publications in international journals. He received the Young Researcher Award from the Turkish Society of Hematology.

• Performs bone marrow transplants and haploidentical stem cell transplantation.
• Provides CAR T-cell therapy and biological treatments for blood cancers.
• Member of the European Society of Hematology and the Turkish Hematology Association.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.